shot-button
Maharashtra Elections 2024 Maharashtra Elections 2024
Home > News > India News > Article > Covid 19 On first day over 2 lakh kids administered vaccine doses

Covid-19: On first day, over 2 lakh kids administered vaccine doses

Updated on: 17 March,2022 09:05 AM IST  |  New Delhi
ANI |

On the first day, 2,60,136 children between the age group of 12-14 with the first dose of COVID -19 vaccines were administered.

Covid-19: On first day, over 2 lakh kids administered vaccine doses

A healthcare worker administers a dose of Covid-19 vaccine to a child in the age group of 12 to 14 years, in Hyderabad. Pic/PTI

On the first day of vaccination for children, more than two lakh vaccine doses were administered with the first dose, said the Ministry of Health and family welfare in an official statement on Thursday.


On the first day, 2,60,136 children between the age group of 12-14 with the first dose of COVID -19 vaccines were administered.


More than 2.15 Crore (2,15,44,283) precaution doses for the identified categories of beneficiaries (HCWs, FLWs and Over 60 years) for COVID vaccination have been administered so far. 


This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK